Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma

Mast cells are a major component of the immune microenvironment in tumour tissues and modulate tumour progression by releasing pro‐tumorigenic and antitumorigenic molecules. Regarding the impact of mast cells on the outcomes of patients with lung adenocarcinoma (LUAD) patient, several published stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Xuanwen, Shi, Run, Zhao, Tianyu, Wang, Yanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191192/
https://www.ncbi.nlm.nih.gov/pubmed/32175651
http://dx.doi.org/10.1002/1878-0261.12670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191192/
https://www.ncbi.nlm.nih.gov/pubmed/32175651
http://dx.doi.org/10.1002/1878-0261.12670

Ejemplares similares